Healthcare provider profile · identity verified

Christopher M Stille, M.D.

Family Practice · DUBUQUE, IA · NPI 1457306615

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	644	182
Levothyroxine Sodium	Levothyroxine Sodium	542	113
Atorvastatin Calcium	Atorvastatin Calcium	477	126
Amlodipine Besylate	Amlodipine Besylate	400	102
Duloxetine Hcl	Duloxetine Hcl	331	87
Metoprolol Succinate	Metoprolol Succinate	326	87
Omeprazole	Omeprazole	319	90
Losartan Potassium	Losartan Potassium	306	83
Lisinopril	Lisinopril	301	87
Furosemide	Furosemide	290	79
Potassium Chloride	Potassium Chloride	248	64
Pantoprazole Sodium	Pantoprazole Sodium	235	68
Pravastatin Sodium	Pravastatin Sodium	215	60
Tamsulosin Hcl	Tamsulosin Hcl	215	58
Simvastatin	Simvastatin	186	44
Fluticasone Propionate	Fluticasone Propionate	181	57
Metoprolol Tartrate	Metoprolol Tartrate	168	50
Allopurinol	Allopurinol	165	45
Gabapentin	Gabapentin	164	50
Glimepiride	Glimepiride	157	48
Metformin Hcl	Metformin Hcl	148	45
Clopidogrel	Clopidogrel Bisulfate	135	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	130	34
Meloxicam	Meloxicam	124	39
Mirtazapine	Mirtazapine	115	32
Atenolol	Atenolol	111	25
Escitalopram Oxalate	Escitalopram Oxalate	110	25
Trazodone Hcl	Trazodone Hcl	99	27
Carvedilol	Carvedilol	95	24
Irbesartan	Irbesartan	95	26
Prednisone	Prednisone	93	67
Celecoxib	Celecoxib	85	31
Lorazepam	Lorazepam	85	24
Eliquis	Apixaban	83	20
Finasteride	Finasteride	82	24
Alendronate Sodium	Alendronate Sodium	76	21
Hydrochlorothiazide	Hydrochlorothiazide	75	24
Myrbetriq	Mirabegron	69	suppressed
Famotidine	Famotidine	68	18
Albuterol Sulfate Hfa	Albuterol Sulfate	64	28
Donepezil Hcl	Donepezil Hcl	63	17
Tramadol Hcl	Tramadol Hcl	63	27
Memantine Hcl	Memantine Hcl	62	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	20
Azithromycin	Azithromycin	56	50
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	56	11
Triamcinolone Acetonide	Triamcinolone Acetonide	56	33
Ropinirole Hcl	Ropinirole Hcl	55	14
Spironolactone	Spironolactone	55	16
Fluoxetine Hcl	Fluoxetine Hcl	52	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	52	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	14
Metformin Hcl Er	Metformin Hcl	47	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	38
Carbamazepine	Carbamazepine	43	suppressed
Ezetimibe	Ezetimibe	42	13
Jardiance	Empagliflozin	41	suppressed
Latanoprost	Latanoprost	41	suppressed
Terazosin Hcl	Terazosin Hcl	41	11
Nifedipine Er	Nifedipine	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	12
Venlafaxine Hcl Er	Venlafaxine Hcl	39	suppressed
Amoxicillin	Amoxicillin	38	20
Sertraline Hcl	Sertraline Hcl	38	13
Pregabalin	Pregabalin	37	13
Montelukast Sodium	Montelukast Sodium	36	14
Clonazepam	Clonazepam	35	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Methylprednisolone	Methylprednisolone	34	29
Alprazolam	Alprazolam	33	suppressed
Colchicine	Colchicine	33	11
Cephalexin	Cephalexin	32	26
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	11
Doxycycline Hyclate	Doxycycline Hyclate	30	30
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	11
Xarelto	Rivaroxaban	28	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Memantine Hcl Er	Memantine Hcl	24	suppressed
Cefdinir	Cefdinir	23	22
Doxepin Hcl	Doxepin Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Metoclopramide Hcl	Metoclopramide Hcl	22	suppressed
Primidone	Primidone	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Oxcarbazepine	Oxcarbazepine	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Nystatin	Nystatin	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Cholestyramine Light	Cholestyramine	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Topiramate	Topiramate	17	suppressed
Fluconazole	Fluconazole	15	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Nitroglycerin	Nitroglycerin	13	11
Pitavastatin Calcium	Pitavastatin Calcium	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Nexlizet	Bempedoic Acid/Ezetimibe	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Roflumilast	Roflumilast	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Ozempic	Semaglutide	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error